Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

A screen displays Republican presidential nominee Donald Trump, after he became U.S. president-elect, at the end of the New ...

Pfizer's stock dropped 4.3 percent while Moderna's fell 3.1 percent and Novavax saw a 2.8 percent dip in its stock Friday ...

U.S. stocks tumbled Friday as the "Trump bump" that Wall Street got from last week's presidential election, along with a cut ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

U.S. stocks suffered their worst loss since election day as the boost from Donald Trump's victory and a Federal Reserve ...

Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy ...

Welcome to The Hill’s Business & Economy newsletter{beacon} Business & Economy Business & Economy   The Big Story Pharma stocks sink after RFK Jr. tapped to lead ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...